Navigation

Vascular disease - clopidogrel and dipyridamole (review) [ID32]

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90)

Status: History
Expected date of issue: December 2010
Process: MTA
Topic area:
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Panagiota Vrouchou and Helen Starkie
Communications manager: Phil Ranson
Project manager: Lori Farrar
Assessment Group / Evidence Review Group: Liverpool Reviews and Implementation Group
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 16 October 2009
1st appraisal committee meeting: 08 July 2010
2nd appraisal committee meeting: 08 September 2010
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers / Sponsors

  • Beacon Pharmaceuticals (clopidogrel)
  • Boehringer-Ingelheim (dipyridamole)
  • Bristol-Myers Squibb Pharmaceuticals and Sanofi-Aventis [joint marketing authorisation] (clopidogrel)
  • Consilient (clopidogrel)

Patient / Carer Groups

  • Anticoagulation Europe (ACE)
  • Diabetes UK
  • HEART UK
  • Heart Care Partnership
  • Insulin Dependent Diabetes Trust (IDDT)
  • Stroke Association

Professional groups

  • Association of British Neurologists
  • British Association of Stroke Physicians
  • British Cardiovascular Society
  • British Cardiovascular Intervention Society (BCIS)
  • British Heart Foundation
  • Royal College of Nursing
  • Royal College of Physicians Cardiology Committee
  • Vascular Society

Others

  • Department of Health
  • Welsh Assembly Government

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare products Regulatory Agency
  • NHS Quality Improvement Scotland

Possible comparator manufacturer(s)

  • Bayer (aspirin)
  • Galpharm-International (aspirin)

Relevant research groups

  • None

Assessment Group

  • Liverpool Reviews & Implementation Group, University of Liverpool
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Project history

Date Update
1st April 2010 The first  Appraisal Committee meeting  will now take place on Thursday 8th July 2010.  The reason for the timing change is to allow time for additional data collection, model development and analysis for inclusion in the Assessment report and is in line with NICE processes. 
Top


 

Key documents

This page was last updated: 23 April 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.